Paper36230613
Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.
Shi Z and 11 others. Cancers (Basel), 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma. Papers, record 36230613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36230613
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81972373 | National Natural Science Foundation of China | PubMed | ||
| PM201809170001 | the Scientific Research Foundation for Advanced Talents of Xiang'an Hospital of Xiamen University | PubMed |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33294119 | Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33294119 | PubMed |
| 2 | 31727869 | A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31727869 | PubMed |
| 3 | 29911113 | Survival outcomes for advanced kidney cancer patients in the era of targeted therapies. | Ann Transl Med | 2018 | https://conductscience.org/library/papers/29911113 | PubMed |
| 4 | 34178024 | Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma. | Front Genet | 2021 | https://conductscience.org/library/papers/34178024 | PubMed |
| 5 | 31184787 | Cancer treatment and survivorship statistics, 2019. | CA Cancer J Clin | 2019 | https://conductscience.org/library/papers/31184787 | PubMed |
| 6 | 21940096 | Lymph node dissection in renal cell carcinoma. | Eur Urol | 2011 | https://conductscience.org/library/papers/21940096 | PubMed |
| 7 | 32939090 | Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. | Nature | 2020 | https://conductscience.org/library/papers/32939090 | PubMed |
| 8 | 32641718 | Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32641718 | PubMed |
| 9 | 33088626 | Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2α pathways in clear cell renal cell carcinoma cells. | PeerJ | 2020 | https://conductscience.org/library/papers/33088626 | PubMed |
| 10 | 34367965 | A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34367965 | PubMed |
| 11 | 35602105 | Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35602105 | PubMed |
| 12 | 34370716 | Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34370716 | PubMed |
| 13 | 33774476 | NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases. | Redox Biol | 2021 | https://conductscience.org/library/papers/33774476 | PubMed |
| 14 | 34281531 | A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34281531 | PubMed |
| 15 | 35459868 | A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. | Nat Commun | 2022 | https://conductscience.org/library/papers/35459868 | PubMed |
| 16 | 25844758 | Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma. | Oncotarget | 2015 | https://conductscience.org/library/papers/25844758 | PubMed |
| 17 | 34950700 | Identification and Validation of CYBB, CD86, and C3AR1 as the Key Genes Related to Macrophage Infiltration of Gastric Cancer. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34950700 | PubMed |
| 18 | 30702258 | Renal Cell Carcinoma: Diagnosis and Management. | Am Fam Physician | 2019 | https://conductscience.org/library/papers/30702258 | PubMed |
| 19 | 33539732 | MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. | Cell Chem Biol | 2021 | https://conductscience.org/library/papers/33539732 | PubMed |
| 20 | 32927333 | Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance. | Crit Rev Oncol Hematol | 2020 | https://conductscience.org/library/papers/32927333 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42669141 | miR-15a-5p Regulates Ferroptosis in Glioblastoma by Targeting GLS2. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42669141 | PubMed |
| 41427530 | Ferroptosis in renal cell carcinoma: integrative multi-omics insights and therapeutic perspectives. | Int J Surg | 2026 | https://conductscience.org/library/papers/41427530 | PubMed |
| 41039547 | Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41039547 | PubMed |
| 40271062 | The biological function and prognostic significance of ferroptosis-related genes in clear cell renal cell carcinoma. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40271062 | PubMed |
| 40078787 | Regulation of Ferroptosis in Cancer and Immune Cells. | Immune Netw | 2025 | https://conductscience.org/library/papers/40078787 | PubMed |
| 39215019 | Prognostic value of KLFs family genes in renal clear cell carcinoma. | Sci Rep | 2024 | https://conductscience.org/library/papers/39215019 | PubMed |
| 38929183 | GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38929183 | PubMed |
| 38397780 | Liproxstatin-1 Alleviated Ischemia/Reperfusion-Induced Acute Kidney Injury via Inhibiting Ferroptosis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38397780 | PubMed |
| 37849802 | The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/37849802 | PubMed |
| 37554789 | Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics. | Heliyon | 2023 | https://conductscience.org/library/papers/37554789 | PubMed |
| 37468683 | Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma. | Sci Rep | 2023 | https://conductscience.org/library/papers/37468683 | PubMed |
| 37426643 | Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37426643 | PubMed |
| 36900214 | Advances in Urological Cancer in 2022, from Basic Approaches to Clinical Management. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900214 | PubMed |
| 36717858 | Identification of ferroptosis related markers by integrated bioinformatics analysis and In vitro model experiments in rheumatoid arthritis. | BMC Med Genomics | 2023 | https://conductscience.org/library/papers/36717858 | PubMed |
| 36358675 | The Association of Tumor Immune Microenvironment of the Primary Lesion with Time to Metastasis in Patients with Renal Cell Carcinoma: A Retrospective Analysis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358675 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36230613
GET https://conductscience.org/api/papers/v1/36230613/references?page=2